NYSE:LCTX | EBITDA | Lineage Cell Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2014-12-31 to 2023-03-31
Data captured

Historical EBITDA

DateEBITDA
2023-03-31-$6.5M
2022-12-31-$6.5M
2022-03-31-$6.25M
2021-12-31-$28.08M
2021-03-31-$6.88M
2020-12-31-$5.68M
2020-09-30-$6.53M
2020-06-30-$6.19M
2020-03-31-$7.23M
2019-12-31-$6.64M
2019-09-30-$8.17M
2019-06-30-$10.58M
2019-03-31-$12.49M
2018-12-31-$9.95M
2018-09-30-$10.1M
2018-06-30-$8.87M
2018-03-31-$11.91M
2017-12-31-$9.29M
2017-09-30-$9.26M
2017-06-30-$8.36M
2017-03-31-$11.05M
2016-12-31-$11.07M
2016-03-31-$23.33M

Annual EBITDA

DateEBITDA
2022-12-31-$21.94M
2021-12-31-$48.55M
2020-12-31-$25.62M
2019-12-31-$37.87M
2018-12-31-$40.71M
2017-12-31-$37.96M
2016-12-31-$57.79M
2015-12-31-$64.73M
2014-12-31-$49.63M